Consensus-based recommendations on cilostazol and standardized Ginkgo biloba combination therapy for secondary stroke prevention and post-stroke cognitive impairment (PSCI) management
Objective: Post-stroke cognitive impairment (PSCI), particularly in patients with cerebral small vessel disease (SVD), remains an important challenge. This Korean NeuroEndovascular Society (KoNES) expert consensus evaluates the rationale for combining cilostazol with standardized Ginkgo biloba extract to address vascular and cognitive aspects of post-stroke care. Methods: An expert panel formulated clinical questions and reviewed randomized trials, meta-analyses, and translational evidence. Recommendations were refined through iterative discussion and review, considering clinical applicability in South Korea. Results: Cilostazol reduces recurrent ischemic stroke risk with a relatively low risk of hemorrhagic complications and may slow white matter lesion progression. Standardized Ginkgo biloba extract, particularly EGb 761, has shown cognitive and functional benefits in selected populations. A standardized extract used in Korea has a broadly similar phytochemical composition, but direct comparative bioequivalence data are lacking. Available pharmacological and clinical evidence suggests complementary mechanisms for the combination, without a clear bleeding signal under studied conditions. Nevertheless, direct evidence of efficacy and safety for combined treatment in stroke populations is limited. Fixed-dose combinations may reduce pill burden when both treatments are indicated. Conclusions: Combining cilostazol with standardized Ginkgo biloba extract may offer a multi-target approach for stroke survivors with SVD or PSCI. Its clinical use should acknowledge the limitations of indirect evidence; prospective randomized trials are needed to establish long-term efficacy and safety.
Authors
- Joonho Chung (ORCID: https://orcid.org/0000-0003-2745-446X)
- Jung Cheol Park (ORCID: https://orcid.org/0000-0001-6677-455X)
- Seung Hun Sheen (ORCID: https://orcid.org/0000-0002-0454-8810)
- Sung-Kon Ha (ORCID: https://orcid.org/0000-0002-0663-9660)
- Keun Young Park (ORCID: https://orcid.org/0000-0002-3254-4577)
- Won Ki Yoon (ORCID: https://orcid.org/0000-0003-3715-0718)
- Sukh Que Park (ORCID: https://orcid.org/0000-0001-5899-179X)
- Young Woo Kim (ORCID: https://orcid.org/0000-0002-5818-950X)
- Dong-Seong Shin (ORCID: https://orcid.org/0000-0001-8633-202X)
- Hoon Kim (ORCID: https://orcid.org/0000-0003-1841-0991)
- Jae Hyung Choi
- Jae Sang Oh
- Dong Young Cho
- Jong Young Lee
Institutions
- Ewha Womans University (KR)
- Hallym University (KR)
- Yonsei University (KR)
- Korea University (KR)
- Soonchunhyang University (KR)
- Severance Hospital (KR)
- Korea University Medical Center (KR)
- Dong-A University Hospital (KR)
- Soonchunhyang University Hospital Seoul (KR)
- Asan Medical Center (KR)
- University of Ulsan (KR)
- The Catholic University of Korea Uijeongbu St. Mary's Hospital (KR)
- CHA University Bundang Medical Center (KR)
- Kangdong Sacred Heart Hospital (KR)
- CHA University (KR)
- Korea University (JP)
- Soonchunhyang University Hospital Bucheon (KR)
- Korea University Guro Hospital (KR)
- Pohang Medical Center (KR)
- Ewha Womans University Seoul Hospital (KR)
- Korea University Ansan Hospital (KR)
- Dong-A University (KR)
- Bucheon University (KR)
- Catholic University of Korea (KR)
Publication Details
- Journal
- Journal of Cerebrovascular and Endovascular Neurosurgery
- Published
- 2026-11-19
- DOI
- https://doi.org/10.7461/jcen.2026.e2026.08.007
- Primary Topic
- Ginkgo biloba and Cashew Applications
- Type
- article
- Field-Weighted Citation Impact
- 0.00